Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
BIOS Health uses data-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines.
Faction is a software company that develops driverless solutions based on light electric vehicles.
Elicit uses language models to help users automate research workflows.
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
MultiOmic Health is building a precision therapeutics discovery platform for metabolic syndrome diseases
Journey Clinical is a platform that provides services to member psychotherapy practices which are independently owned and operated.
AI-powered digital therapeutics for mind-body conditions, starting with IBS.
Solving disease-related malnutrition with a mobile clinical assistant for healthcare professionals.
Opentrons is a life science company that develops pipetting robot technology designed to automate experiments.
Brightseed uses artificial intelligence and machine learning to discover the potential of plant compounds for various applications.
Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology.
Onepot.ai offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process.
Arpeggio builds technology to watch and learn how drugs work.
Gridware is a grid‑technology company dedicated to improving safety and reliability on the electrical transmission and distribution systems.
Red Queen Bio works with frontier labs to map AI-enabled biothreats and pre-build medical countermeasures against them.
Adaptation creates AI systems that adjust to changing real-world circumstances.
Substack is a subscription-based newsletter publishing platform for independent writers.
Onepot AI offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process.
Planet A Foods is a B2B sustainable ingredients company that specializes in the production of cocoa-free chocolate.
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
Electroflow Technologies is a chemical manufacturing company that specializes in developing battery materials for energy abundance.
Harmonic Discovery operates as a pharmaceutical company that develops a platform that combines computing and experimentation.
One Platform, Many Proteins
Rad AI develops software that uses AI to automate radiology report writing, aiming to enhance accuracy and reduce radiologist burnout.
Fifty Years has invested in 87 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fifty Years's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics, Pharmaceutical. The firm invests across 51 different industry categories.
Among tracked funding rounds, Gridware received $55.0M in a Series B round. Fifty Years's total known invested capital is $1.3B.
Fifty Years's average investment size is $15.6M across its portfolio of 87 companies.
Recent Fifty Years portfolio additions include BIOS, Faction, Elicit, Cofactor Genomics, MultiOmic Health. These companies were founded in 2020 or later.